Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F20%3A10416107" target="_blank" >RIV/00216208:11110/20:10416107 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/20:00116718 RIV/00216208:11140/20:10416107 RIV/65269705:_____/20:00073262 RIV/00669806:_____/20:10416107 RIV/00023001:_____/20:00080453
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=o5pik7FSNr" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=o5pik7FSNr</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00038-020-01496-y" target="_blank" >10.1007/s00038-020-01496-y</a>
Alternative languages
Result language
angličtina
Original language name
Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics
Original language description
Objectives The MOSAIC study gathered data on chronic hepatitis C virus (HCV) infection and its treatment in various countries worldwide. Here we summarise patient and HCV characteristics in the Czech Republic and Slovakia. Methods MOSAIC was an observational study that included patients with chronic HCV infection untreated at the time of enrolment. Study collected and descriptively analysed patient demographics, disease stage and viral characteristics. Data were collected between February 2014 to October 2014. Results Among 220 patients enrolled, 51.4% were treatment-naıve. The most prevalent HCV genotype was G1 (78.4%), followed by G3 (19.7%). Higher prevalence of G1 was found in treatment-experienced patients (94.3%) compared to treatment-naıve (63.4%). Most participants (67.7%) presented viral RNA load of C 800,000 IU/mL. Liver cirrhosis was reported in 24.5% of patients. Higher HCV RNA load and duration of HCV infection correlated with the degree of liver fibrosis. Anti-HCV interferon-based treatments were initiated in 88.2% of participants. Conclusions The study confirmed significant changes in the HCV genotypes partition with G3 genotype rapidly increasing in both countries, with possible impact on the WHO eradication initiative and treatment selection.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30219 - Gastroenterology and hepatology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Public Health
ISSN
1661-8556
e-ISSN
—
Volume of the periodical
65
Issue of the periodical within the volume
9
Country of publishing house
CH - SWITZERLAND
Number of pages
13
Pages from-to
1723-1735
UT code for WoS article
000576627700002
EID of the result in the Scopus database
2-s2.0-85092385126